Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.880
+0.015 (0.80%)
Jul 24, 2026, 4:27 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 456.34 million as of July 24, 2026. Its market cap has decreased by -30.37% in one year.
Market Cap
456.34M
Enterprise Value
457.36M
Revenue
51.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.88
ChartMarket Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 456.34M, an increase of 318.94%. That is a compound annual growth rate of 9.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 456.34M | -1.05% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.54B |
| Nanexa AB | 678.17M |
| Dicot Pharma AB | 622.98M |
| EQL Pharma AB | 608.31M |
| Cinclus Pharma Holding AB | 555.66M |
| Orexo AB | 532.21M |
| Moberg Pharma AB | 438.52M |
| Klaria Pharma Holding AB (publ.) | 193.83M |